Gynecologic Cancer InterGroup (GCIG) consensus review for vulvovaginal melanomas.
Identifieur interne : 003518 ( PubMed/Checkpoint ); précédent : 003517; suivant : 003519Gynecologic Cancer InterGroup (GCIG) consensus review for vulvovaginal melanomas.
Auteurs : Mario M. Leitao [France] ; Xi Cheng ; Anne L. Hamilton ; Nadeem A. Siddiqui ; Ina Jurgenliemk-Schulz ; Sven Mahner ; Elisabeth Vall-Lundqvist ; Kidong Kim ; Gilles FreyerSource :
- International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [ 1525-1438 ] ; 2014.
Descripteurs français
- KwdFr :
- Association thérapeutique, Consensus, Femelle, Guides de bonnes pratiques cliniques comme sujet, Humains, Mélanome (), Mélanome (anatomopathologie), Oncologie médicale, Sociétés médicales, Tumeurs de la vulve (), Tumeurs de la vulve (anatomopathologie), Tumeurs du vagin (), Tumeurs du vagin (anatomopathologie).
- MESH :
English descriptors
- KwdEn :
- MESH :
Abstract
Vulvovaginal melanomas are rare tumors that account for a small fraction of all vulvovaginal cancers. Biologically, they seem to be similar to mucosal and acral melanomas of other sites. There are limited data specific to vulvovaginal melanomas, especially regarding systemic therapies. Most treatment decisions are based on extrapolation from data regarding cutaneous melanomas of other sites. It is reasonable to follow already established guidelines from other professional groups and societies. Outcomes tend to be worse compared with cutaneous melanomas likely because of the later presentation and physical biological characteristics of these tumors.
DOI: 10.1097/IGC.0000000000000198
PubMed: 24987924
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:24987924Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Gynecologic Cancer InterGroup (GCIG) consensus review for vulvovaginal melanomas.</title><author><name sortKey="Leitao, Mario M" sort="Leitao, Mario M" uniqKey="Leitao M" first="Mario M" last="Leitao">Mario M. Leitao</name><affiliation wicri:level="3"><nlm:affiliation>*Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; †Fudan University Shanghai Cancer Center, Shanghai, China; ‡Peter MacCallum Cancer Centre, Melbourne, Australia; §Royal Women's Hospital, Melbourne, Australia; ∥University of Melbourne, Melbourne, Australia; ¶Glasgow Royal Infirmary, Gynaecology Administration Block, Glasgow, Scotland; #Department of Radiation Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands; **Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; ††Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden; ‡‡Department of Obstetrics & Gynecology, Seoul National University Bundang Hospital, Seoul, Korea; and §§Service d'Oncologie Médicale, Centre Hospitalier Lyon-Sud, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>*Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; †Fudan University Shanghai Cancer Center, Shanghai, China; ‡Peter MacCallum Cancer Centre, Melbourne, Australia; §Royal Women's Hospital, Melbourne, Australia; ∥University of Melbourne, Melbourne, Australia; ¶Glasgow Royal Infirmary, Gynaecology Administration Block, Glasgow, Scotland; #Department of Radiation Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands; **Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; ††Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden; ‡‡Department of Obstetrics & Gynecology, Seoul National University Bundang Hospital, Seoul, Korea; and §§Service d'Oncologie Médicale, Centre Hospitalier Lyon-Sud, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Cheng, Xi" sort="Cheng, Xi" uniqKey="Cheng X" first="Xi" last="Cheng">Xi Cheng</name></author><author><name sortKey="Hamilton, Anne L" sort="Hamilton, Anne L" uniqKey="Hamilton A" first="Anne L" last="Hamilton">Anne L. Hamilton</name></author><author><name sortKey="Siddiqui, Nadeem A" sort="Siddiqui, Nadeem A" uniqKey="Siddiqui N" first="Nadeem A" last="Siddiqui">Nadeem A. Siddiqui</name></author><author><name sortKey="Jurgenliemk Schulz, Ina" sort="Jurgenliemk Schulz, Ina" uniqKey="Jurgenliemk Schulz I" first="Ina" last="Jurgenliemk-Schulz">Ina Jurgenliemk-Schulz</name></author><author><name sortKey="Mahner, Sven" sort="Mahner, Sven" uniqKey="Mahner S" first="Sven" last="Mahner">Sven Mahner</name></author><author><name sortKey=" Vall Lundqvist, Elisabeth" sort=" Vall Lundqvist, Elisabeth" uniqKey=" Vall Lundqvist E" first="Elisabeth" last=" Vall-Lundqvist">Elisabeth Vall-Lundqvist</name></author><author><name sortKey="Kim, Kidong" sort="Kim, Kidong" uniqKey="Kim K" first="Kidong" last="Kim">Kidong Kim</name></author><author><name sortKey="Freyer, Gilles" sort="Freyer, Gilles" uniqKey="Freyer G" first="Gilles" last="Freyer">Gilles Freyer</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24987924</idno><idno type="pmid">24987924</idno><idno type="doi">10.1097/IGC.0000000000000198</idno><idno type="wicri:Area/PubMed/Corpus">003308</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003308</idno><idno type="wicri:Area/PubMed/Curation">003198</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003198</idno><idno type="wicri:Area/PubMed/Checkpoint">003198</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003198</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Gynecologic Cancer InterGroup (GCIG) consensus review for vulvovaginal melanomas.</title><author><name sortKey="Leitao, Mario M" sort="Leitao, Mario M" uniqKey="Leitao M" first="Mario M" last="Leitao">Mario M. Leitao</name><affiliation wicri:level="3"><nlm:affiliation>*Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; †Fudan University Shanghai Cancer Center, Shanghai, China; ‡Peter MacCallum Cancer Centre, Melbourne, Australia; §Royal Women's Hospital, Melbourne, Australia; ∥University of Melbourne, Melbourne, Australia; ¶Glasgow Royal Infirmary, Gynaecology Administration Block, Glasgow, Scotland; #Department of Radiation Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands; **Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; ††Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden; ‡‡Department of Obstetrics & Gynecology, Seoul National University Bundang Hospital, Seoul, Korea; and §§Service d'Oncologie Médicale, Centre Hospitalier Lyon-Sud, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>*Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; †Fudan University Shanghai Cancer Center, Shanghai, China; ‡Peter MacCallum Cancer Centre, Melbourne, Australia; §Royal Women's Hospital, Melbourne, Australia; ∥University of Melbourne, Melbourne, Australia; ¶Glasgow Royal Infirmary, Gynaecology Administration Block, Glasgow, Scotland; #Department of Radiation Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands; **Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; ††Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden; ‡‡Department of Obstetrics & Gynecology, Seoul National University Bundang Hospital, Seoul, Korea; and §§Service d'Oncologie Médicale, Centre Hospitalier Lyon-Sud, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Cheng, Xi" sort="Cheng, Xi" uniqKey="Cheng X" first="Xi" last="Cheng">Xi Cheng</name></author><author><name sortKey="Hamilton, Anne L" sort="Hamilton, Anne L" uniqKey="Hamilton A" first="Anne L" last="Hamilton">Anne L. Hamilton</name></author><author><name sortKey="Siddiqui, Nadeem A" sort="Siddiqui, Nadeem A" uniqKey="Siddiqui N" first="Nadeem A" last="Siddiqui">Nadeem A. Siddiqui</name></author><author><name sortKey="Jurgenliemk Schulz, Ina" sort="Jurgenliemk Schulz, Ina" uniqKey="Jurgenliemk Schulz I" first="Ina" last="Jurgenliemk-Schulz">Ina Jurgenliemk-Schulz</name></author><author><name sortKey="Mahner, Sven" sort="Mahner, Sven" uniqKey="Mahner S" first="Sven" last="Mahner">Sven Mahner</name></author><author><name sortKey=" Vall Lundqvist, Elisabeth" sort=" Vall Lundqvist, Elisabeth" uniqKey=" Vall Lundqvist E" first="Elisabeth" last=" Vall-Lundqvist">Elisabeth Vall-Lundqvist</name></author><author><name sortKey="Kim, Kidong" sort="Kim, Kidong" uniqKey="Kim K" first="Kidong" last="Kim">Kidong Kim</name></author><author><name sortKey="Freyer, Gilles" sort="Freyer, Gilles" uniqKey="Freyer G" first="Gilles" last="Freyer">Gilles Freyer</name></author></analytic><series><title level="j">International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</title><idno type="eISSN">1525-1438</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Combined Modality Therapy</term><term>Consensus</term><term>Female</term><term>Humans</term><term>Medical Oncology</term><term>Melanoma (pathology)</term><term>Melanoma (therapy)</term><term>Practice Guidelines as Topic</term><term>Societies, Medical</term><term>Vaginal Neoplasms (pathology)</term><term>Vaginal Neoplasms (therapy)</term><term>Vulvar Neoplasms (pathology)</term><term>Vulvar Neoplasms (therapy)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Association thérapeutique</term><term>Consensus</term><term>Femelle</term><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term><term>Mélanome ()</term><term>Mélanome (anatomopathologie)</term><term>Oncologie médicale</term><term>Sociétés médicales</term><term>Tumeurs de la vulve ()</term><term>Tumeurs de la vulve (anatomopathologie)</term><term>Tumeurs du vagin ()</term><term>Tumeurs du vagin (anatomopathologie)</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Mélanome</term><term>Tumeurs de la vulve</term><term>Tumeurs du vagin</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Melanoma</term><term>Vaginal Neoplasms</term><term>Vulvar Neoplasms</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Melanoma</term><term>Vaginal Neoplasms</term><term>Vulvar Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Combined Modality Therapy</term><term>Consensus</term><term>Female</term><term>Humans</term><term>Medical Oncology</term><term>Practice Guidelines as Topic</term><term>Societies, Medical</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Association thérapeutique</term><term>Consensus</term><term>Femelle</term><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term><term>Mélanome</term><term>Oncologie médicale</term><term>Sociétés médicales</term><term>Tumeurs de la vulve</term><term>Tumeurs du vagin</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Vulvovaginal melanomas are rare tumors that account for a small fraction of all vulvovaginal cancers. Biologically, they seem to be similar to mucosal and acral melanomas of other sites. There are limited data specific to vulvovaginal melanomas, especially regarding systemic therapies. Most treatment decisions are based on extrapolation from data regarding cutaneous melanomas of other sites. It is reasonable to follow already established guidelines from other professional groups and societies. Outcomes tend to be worse compared with cutaneous melanomas likely because of the later presentation and physical biological characteristics of these tumors.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24987924</PMID><DateCreated><Year>2014</Year><Month>10</Month><Day>24</Day></DateCreated><DateCompleted><Year>2015</Year><Month>07</Month><Day>07</Day></DateCompleted><DateRevised><Year>2014</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1525-1438</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>9 Suppl 3</Issue><PubDate><Year>2014</Year><Month>Nov</Month></PubDate></JournalIssue><Title>International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</Title><ISOAbbreviation>Int. J. Gynecol. Cancer</ISOAbbreviation></Journal><ArticleTitle>Gynecologic Cancer InterGroup (GCIG) consensus review for vulvovaginal melanomas.</ArticleTitle><Pagination><MedlinePgn>S117-22</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/IGC.0000000000000198</ELocationID><Abstract><AbstractText>Vulvovaginal melanomas are rare tumors that account for a small fraction of all vulvovaginal cancers. Biologically, they seem to be similar to mucosal and acral melanomas of other sites. There are limited data specific to vulvovaginal melanomas, especially regarding systemic therapies. Most treatment decisions are based on extrapolation from data regarding cutaneous melanomas of other sites. It is reasonable to follow already established guidelines from other professional groups and societies. Outcomes tend to be worse compared with cutaneous melanomas likely because of the later presentation and physical biological characteristics of these tumors.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leitao</LastName><ForeName>Mario M</ForeName><Initials>MM</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>*Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; †Fudan University Shanghai Cancer Center, Shanghai, China; ‡Peter MacCallum Cancer Centre, Melbourne, Australia; §Royal Women's Hospital, Melbourne, Australia; ∥University of Melbourne, Melbourne, Australia; ¶Glasgow Royal Infirmary, Gynaecology Administration Block, Glasgow, Scotland; #Department of Radiation Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands; **Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; ††Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden; ‡‡Department of Obstetrics & Gynecology, Seoul National University Bundang Hospital, Seoul, Korea; and §§Service d'Oncologie Médicale, Centre Hospitalier Lyon-Sud, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Xi</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Anne L</ForeName><Initials>AL</Initials></Author><Author ValidYN="Y"><LastName>Siddiqui</LastName><ForeName>Nadeem A</ForeName><Initials>NA</Initials></Author><Author ValidYN="Y"><LastName>Jurgenliemk-Schulz</LastName><ForeName>Ina</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Mahner</LastName><ForeName>Sven</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Åvall-Lundqvist</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Kidong</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Freyer</LastName><ForeName>Gilles</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Gynecol Cancer</MedlineTA><NlmUniqueID>9111626</NlmUniqueID><ISSNLinking>1048-891X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D032921" MajorTopicYN="N">Consensus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008495" MajorTopicYN="Y">Medical Oncology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008545" MajorTopicYN="N">Melanoma</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012955" MajorTopicYN="N">Societies, Medical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014625" MajorTopicYN="N">Vaginal Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014846" MajorTopicYN="N">Vulvar Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24987924</ArticleId><ArticleId IdType="doi">10.1097/IGC.0000000000000198</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Auvergne-Rhône-Alpes</li><li>Rhône-Alpes</li></region><settlement><li>Lyon</li></settlement></list><tree><noCountry><name sortKey=" Vall Lundqvist, Elisabeth" sort=" Vall Lundqvist, Elisabeth" uniqKey=" Vall Lundqvist E" first="Elisabeth" last=" Vall-Lundqvist">Elisabeth Vall-Lundqvist</name><name sortKey="Cheng, Xi" sort="Cheng, Xi" uniqKey="Cheng X" first="Xi" last="Cheng">Xi Cheng</name><name sortKey="Freyer, Gilles" sort="Freyer, Gilles" uniqKey="Freyer G" first="Gilles" last="Freyer">Gilles Freyer</name><name sortKey="Hamilton, Anne L" sort="Hamilton, Anne L" uniqKey="Hamilton A" first="Anne L" last="Hamilton">Anne L. Hamilton</name><name sortKey="Jurgenliemk Schulz, Ina" sort="Jurgenliemk Schulz, Ina" uniqKey="Jurgenliemk Schulz I" first="Ina" last="Jurgenliemk-Schulz">Ina Jurgenliemk-Schulz</name><name sortKey="Kim, Kidong" sort="Kim, Kidong" uniqKey="Kim K" first="Kidong" last="Kim">Kidong Kim</name><name sortKey="Mahner, Sven" sort="Mahner, Sven" uniqKey="Mahner S" first="Sven" last="Mahner">Sven Mahner</name><name sortKey="Siddiqui, Nadeem A" sort="Siddiqui, Nadeem A" uniqKey="Siddiqui N" first="Nadeem A" last="Siddiqui">Nadeem A. Siddiqui</name></noCountry><country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Leitao, Mario M" sort="Leitao, Mario M" uniqKey="Leitao M" first="Mario M" last="Leitao">Mario M. Leitao</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003518 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 003518 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:24987924
|texte= Gynecologic Cancer InterGroup (GCIG) consensus review for vulvovaginal melanomas.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:24987924" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |